News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
760,221 Results
Type
Article (48422)
Company Profile (364)
Press Release (711421)
Multimedia
Podcasts (107)
Webinars (21)
Section
Business (212713)
Career Advice (2167)
Deals (36598)
Drug Delivery (127)
Drug Development (87487)
Employer Resources (178)
FDA (17216)
Job Trends (15536)
News (362516)
Policy (34303)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2816)
Academic (1)
Accelerated approval (37)
Adcomms (34)
Allergies (157)
Alliances (52337)
ALS (185)
Alzheimer's disease (1793)
Antibody-drug conjugate (ADC) (340)
Approvals (17460)
Artificial intelligence (583)
Autoimmune disease (176)
Automation (44)
Bankruptcy (371)
Best Places to Work (12038)
BIOSECURE Act (22)
Biosimilars (201)
Biotechnology (239)
Bladder cancer (165)
Brain cancer (65)
Breast cancer (673)
Cancer (5106)
Cardiovascular disease (437)
Career advice (1835)
Career pathing (39)
CAR-T (301)
CDC (50)
Celiac Disease (2)
Cell therapy (800)
Cervical cancer (38)
Clinical research (74567)
Collaboration (1842)
Company closure (4)
Compensation (1211)
Complete response letters (67)
COVID-19 (2899)
CRISPR (101)
C-suite (918)
Cystic fibrosis (151)
Data (6492)
Decentralized trials (2)
Denatured (36)
Depression (151)
Diabetes (523)
Diagnostics (7086)
Digital health (50)
Diversity (13)
Diversity, equity & inclusion (47)
Drug discovery (274)
Drug pricing (191)
Drug shortages (29)
Duchenne muscular dystrophy (244)
Earnings (91957)
Editorial (64)
Employer branding (22)
Employer resources (157)
Events (123321)
Executive appointments (1037)
FDA (20487)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1567)
Gene editing (217)
Generative AI (52)
Gene therapy (647)
GLP-1 (1049)
Government (4892)
Grass and pollen (8)
Guidances (384)
Healthcare (19865)
HIV (67)
Huntington's disease (49)
IgA nephropathy (88)
Immunology and inflammation (284)
Immuno-oncology (69)
Indications (122)
Infectious disease (3191)
Inflammatory bowel disease (213)
Inflation Reduction Act (14)
Influenza (126)
Intellectual property (262)
Interviews (342)
IPO (17077)
IRA (50)
Job creations (3845)
Job search strategy (1540)
JPM (57)
Kidney cancer (17)
Labor market (87)
Layoffs (602)
Leadership (39)
Legal (8177)
Liver cancer (94)
Longevity (17)
Lung cancer (690)
Lymphoma (389)
Machine learning (43)
Management (59)
Manufacturing (839)
MASH (173)
Medical device (14364)
Medtech (14426)
Mergers & acquisitions (20619)
Metabolic disorders (1338)
Multiple sclerosis (170)
NASH (16)
Neurodegenerative disease (360)
Neuropsychiatric disorders (97)
Neuroscience (3136)
Neurotech (1)
NextGen: Class of 2026 (6903)
Non-profit (4753)
Now hiring (68)
Obesity (635)
Opinion (307)
Ovarian cancer (170)
Pain (216)
Pancreatic cancer (243)
Parkinson's disease (303)
Partnered (35)
Patents (520)
Patient recruitment (524)
Peanut (63)
People (61726)
Pharmaceutical (77)
Pharmacy benefit managers (30)
Phase 1 (23394)
Phase 2 (32755)
Phase 3 (24368)
Pipeline (5642)
Policy (301)
Postmarket research (2796)
Preclinical (9770)
Press Release (68)
Prostate cancer (250)
Psychedelics (52)
Radiopharmaceuticals (303)
Rare diseases (929)
Real estate (6342)
Recruiting (72)
Regulatory (25944)
Reports (53)
Research institute (2618)
Resumes & cover letters (366)
Rett syndrome (28)
RNA editing (18)
RSV (83)
Schizophrenia (160)
Series A (258)
Series B (203)
Service/supplier (16)
Sickle cell disease (102)
Special edition (25)
Spinal muscular atrophy (169)
Sponsored (44)
Startups (3872)
State (2)
Stomach cancer (20)
Supply chain (110)
Tariffs (85)
The Weekly (69)
Vaccines (1083)
Venture capital (94)
Weight loss (414)
Women's health (100)
Worklife (20)
Date
Today (163)
Last 7 days (733)
Last 30 days (2506)
Last 365 days (31221)
2026 (4370)
2025 (31494)
2024 (36640)
2023 (41578)
2022 (52956)
2021 (57491)
2020 (56048)
2019 (48813)
2018 (36876)
2017 (34004)
2016 (33609)
2015 (39544)
2014 (33364)
2013 (28396)
2012 (30503)
2011 (31126)
2010 (29202)
Location
Africa (824)
Alabama (87)
Alaska (7)
Arizona (329)
Arkansas (13)
Asia (42686)
Australia (7211)
California (11718)
Canada (3376)
China (1184)
Colorado (492)
Connecticut (505)
Delaware (350)
Europe (94753)
Florida (1763)
Georgia (381)
Hawaii (3)
Idaho (65)
Illinois (906)
India (73)
Indiana (542)
Iowa (23)
Japan (443)
Kansas (131)
Kentucky (40)
Louisiana (28)
Maine (72)
Maryland (1448)
Massachusetts (8518)
Michigan (334)
Minnesota (656)
Mississippi (6)
Missouri (133)
Montana (36)
Nebraska (28)
Nevada (129)
New Hampshire (85)
New Jersey (3076)
New Mexico (32)
New York (3109)
North Carolina (1589)
North Dakota (10)
Northern California (5700)
Ohio (355)
Oklahoma (22)
Oregon (45)
Pennsylvania (2359)
Puerto Rico (25)
Rhode Island (49)
South America (1195)
South Carolina (70)
South Dakota (1)
Southern California (4582)
Tennessee (182)
Texas (1816)
United States (41851)
Utah (358)
Vermont (1)
Virginia (277)
Washington D.C. (83)
Washington State (965)
West Virginia (4)
Wisconsin (120)
Wyoming (2)
760,221 Results for "enzo biochem clinical labs inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enzo Biochem, Inc. To be Acquired by Battery Ventures in All-Cash Transaction
June 24, 2025
·
7 min read
Press Releases
Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results
June 17, 2025
·
7 min read
Business
Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update
Enzo Biochem, Inc. announced financial results for the fiscal third quarter ended April 30, 2024.
June 13, 2024
·
9 min read
Press Releases
Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential Transaction
April 22, 2025
·
4 min read
Business
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the second quarter ended January 31, 2024.
March 13, 2024
·
8 min read
Deals
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has closed a transaction to sell certain assets of Enzo’s Clinical laboratory division (Enzo Clinical Labs) to Laboratory Corporation of America Holdings (Labcorp) (NYSE:LH) pursuant to an Asset Purchase Agreement dated March 16, 2023, as amended July 3, 2023.
July 24, 2023
·
3 min read
Press Releases
Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results
March 18, 2025
·
7 min read
Business
ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE
Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the first quarter ended October 31, 2023.
December 15, 2023
·
4 min read
Business
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
Enzo Biochem, Inc., a leading life science company, announced the voting results from its Annual Meeting held on January 31, 2024 and officer appointments.
February 1, 2024
·
3 min read
Deals
Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Sale
Enzo Biochem, Inc., announced that the preliminary voting results from the Inspector of Election at today’s Special Meeting of the Shareholders indicate that the Asset Sale Proposal was approved by the affirmative vote of a majority of Enzo’s outstanding common stock.
May 22, 2023
·
2 min read
1 of 76,023
Next
